Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction

Heart

Volumn 100, Issue 8, 2014, Pages 652-657

  Liebetrau, Christoph ^a,b   Nef, Holger M ^c   Dörr, Oliver ^c   Gaede, Luise ^a,b   Hoffmann, Jedrzej ^a,b   Hahnel, Astrid ^a,b   Rolf, Andreas ^a,b   Troidl, Christian ^a,b   Lackner, Karl J ^d   Keller, Till ^b,e   Hamm, Christian W ^a,b,c   Möllmann, Helge ^a,b  

^a Department of Cardiology Kerckhoff Heart and Thorax Center ^*  (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; ISCHEMIA MODIFIED ALBUMIN; TROPONIN T; VASCULOTROPIN RECEPTOR 1;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; TRANSCORONARY ABLATION OF SEPTAL HYPERTROPHY;

ABLATION TECHNIQUES; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; EARLY DIAGNOSIS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOASSAY; KINETICS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; SERUM ALBUMIN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84897115491     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305253     Document Type: Article

References (31)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57. (Pubitemid 43767064)
2. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
3. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
4. Weber M, Bazzino O, Navarro Estrada JL, et al. Improved diagnostic and prognostic performance of a new high sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 2011;162:81-8.
5. Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010;56:642-50.
6. Backus BE, Six AJ, Kelder JH, et al. Risk scores for patients with chest pain: evaluation in the emergency department. Curr Cardiol Rev 2011;7:2-8.
7. Forberg JL, Henriksen LS, Edenbrandt L, et al. Direct hospital costs of chest pain patients attending the emergency department: a retrospective study. BMC Emerg Med 2006;6:6.
8. Hochholzer W, Reichlin T, Stelzig C, et al. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur Heart J 2011;32:326-35.
9. Kurz K, Giannitsis E, Becker M, et al. Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 2011;100:209-15.
10. Oemrawsingh RM, Lenderink T, Akkerhuis KM, et al. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome. Heart 2011;97:1061-6.
11. Shen XL, Lin CJ, Han LL, et al. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol 2011;149:296-8.
12. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
13. McMahon CG, Lamont JV, Curtin E, et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med 2012;30:267-74.
14. Body R, Carley S, McDowell G, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58:1332-9.
15. Hessel MH, Michielsen EC, Atsma DE, et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol 2008;85:90-5.
16. Clements P, Brady S, York M, et al. Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat. Toxicol Pathol 2010;38:703-14.
17. Vikenes K, Westby J, Matre K, et al. Release of cardiac troponin T after temporally graded acute coronary ischaemia with electrocardiographic ST depression. Int J Cardiol 2002;85:243-51. (Pubitemid 35245987)
18. Smithline HA, Thompson M, Moran C, et al. Can CK-MB and cTn-I be detected in the peripheral circulation within the first min of acute coronary ischemia? Med Hypotheses 2003;60:598-602 (Pubitemid 36315296)
19. Kapur NK, Heffernan KS, Yunis AA, et al. Elevated soluble fms-like tyrosine kinase-1 levels in acute coronary occlusion. Arterioscler Thromb Vasc Biol 2011;31:443-50.
20. Liebetrau C, Möllmann H, Nef H, et al. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem 2012;58:1049-54.
21. Liebetrau C, Nef H, Szardien S, et al. Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem 2013;59:566-9.
22. Liebetrau C, Möllmann H, Dörr O, et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol 2013;62:992-8.
23. Liebetrau C, Gaede L, Dörr O, et al. Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction. Clin Chim Acta 2013;429C:34-7.
24. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-713. (Pubitemid 37383745)
25. Rosenberg VA, Buhimschi IA, Lockwood CJ, et al. Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy. Circulation 2011;124:2543-53.
26. Searle J, Mockel M, Gwosc S, et al. Heparin strongly induces soluble fms like tyrosine kinase release in vivo and in vitro - brief report. Arterioscler Thromb Vasc Biol 2011;31:2972-4.
27. McCann CJ, Glover BM, Menown IB, et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol 2009;103:22-8.
28. Van Belle E, Gallongeville J, Vicaut E, et al. Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J 2010;159:570-6.
29. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54: 60-8.
30. Hjortshoj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia-modified albumin in patients with suspected coronary syndrome. Am J Emerg Med 2010;28:170-6.
31. Body R, Dixon D, Burrows G, et al. Economic evaluation of a heart fatty acid binding protein based protocol for rapid chest pain assessment. 14th International Conference on Emergency Medicine. Acad Emerg Med 2012;19:746-7.